Abstract
Dual NOX4/NOX1 inhibition by setanaxib halts cholangiocarcinoma progression by impairing cancer associated fibroblast activation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.freeradbiomed.2024.04.160
Publication Date: Jun 1, 2024 |
Dual NOX4/NOX1 inhibition by setanaxib halts cholangiocarcinoma progression by impairing cancer associated fibroblast activation
Join us for a 30 min session where you can share your feedback and ask us any queries you have